Drug Pipeline

Ferric Derisomaltose Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
6
Recruiting
2
Phase 3
6
Top Sponsors
Active Studies by Phase
Phase 4
3
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04945707 Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF… Iron-deficiency Recruiting
NCT04913649 Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients Iron Deficiency Anemia Recruiting
NCT06898814 The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture… Hip Fracture Recruiting
Phase 3
NCT05179226 Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron… Iron Deficiency, Anaemia in Children Recruiting
NCT06884280 Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The… Peritoneal Dialysis Recruiting
Phase 2
NCT06287619 Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing… Chronic Iron Deficiency Anaemia Recruiting
Sponsors Running Ferric Derisomaltose Trials
dr. P. Noordzij (1) Massachusetts General Hospital (1) Pharmacosmos A/S (1) University Health Network, Toronto (1) Hull University Teaching Hospitals NHS Trust (1) Soren Overgaard (1)
Disease Areas
Heart Failure (1)
Get alerts when Ferric Derisomaltose trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free